Publicacións en colaboración con investigadores/as de Columbia University Medical Center (27)

2022

  1. Comparative functional genomics identifies unique molecular features of EPSCs

    Life Science Alliance, Vol. 5, Núm. 11

2021

  1. Phase separation of OCT4 controls TAD reorganization to promote cell fate transitions

    Cell Stem Cell, Vol. 28, Núm. 10, pp. 1868-1883.e11

2020

  1. ADAR1-Dependent RNA Editing Promotes MET and iPSC Reprogramming by Alleviating ER Stress

    Cell Stem Cell, Vol. 27, Núm. 2, pp. 300-314.e11

  2. An Optimized Immunoprecipitation Protocol for Assessing Protein-RNA Interactions In Vitro

    STAR Protocols, Vol. 1, Núm. 2

  3. Broad Spectrum project: Factors determining the quality of antibiotic use in primary care: An observational study protocol from Italy

    BMJ Open, Vol. 10, Núm. 7

  4. Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation

    Nature Communications, Vol. 11, Núm. 1

2017

  1. New insights into highly potent tyrosinase inhibitors based on 3-heteroarylcoumarins: Anti-melanogenesis and antioxidant activities, and computational molecular modeling studies

    Bioorganic and Medicinal Chemistry, Vol. 25, Núm. 5, pp. 1687-1695

2016

  1. Computational Drug Target Screening through Protein Interaction Profiles

    Scientific Reports, Vol. 6

  2. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond

    PLoS Pathogens, Vol. 12, Núm. 7

  3. Progress in the development of small molecules as new human A3 adenosine receptor ligands based on the 3-thiophenylcoumarin core

    MedChemComm, Vol. 7, Núm. 5, pp. 845-852

2015

  1. Design and discovery of tyrosinase inhibitors based on a coumarin scaffold

    RSC Advances, Vol. 5, Núm. 114, pp. 94227-94235

  2. Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold

    Bioorganic Chemistry, Vol. 61, pp. 1-6

  3. Navigating in chromone chemical space: Discovery of novel and distinct A3 adenosine receptor ligands

    RSC Advances, Vol. 5, Núm. 96, pp. 78572-78585

  4. Potent and selective MAO-B inhibitory activity: Amino- versus nitro-3-arylcoumarin derivatives

    Bioorganic and Medicinal Chemistry Letters, Vol. 25, Núm. 3, pp. 642-648

2014

  1. Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition

    ChemMedChem, Vol. 9, Núm. 7, pp. 1488-1500

  2. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins

    ChemMedChem, Vol. 9, Núm. 8, pp. 1672-1676

  3. Similarity-based modeling in large-scale prediction of drug-drug interactions

    Nature Protocols, Vol. 9, Núm. 9, pp. 2147-2163

  4. State of the art and development of a drug-drug interaction large scale predictor based on 3D pharmacophoric similarity

    Current Drug Metabolism, Vol. 15, Núm. 5, pp. 490-501

  5. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases

    Future Medicinal Chemistry, Vol. 6, Núm. 4, pp. 371-383

2013

  1. Comparative study of the 3-phenylcoumarin scaffold: Synthesis, X-ray structural analysis and semiempirical calculations of a selected series of compounds

    Journal of Molecular Structure, Vol. 1050, pp. 185-191